Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

被引：0
|
作者：
Wei Han
Nan Wang
Rui Kong
Wen Bao
Jie Lu
机构：
[1] Tongji University School of Medicine,Department of Gastroenterology, Shanghai Tenth People’s Hospital
[2] Gongli Hospital of Shanghai Pudong New Area,Department of Gastroenterology
来源：
Journal of Translational Medicine | / 20卷
关键词：
PPARδ; HCC; Prognosis; PI3K-AKT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway
    Zhiwei Xue
    Jiwei Wang
    Zide Wang
    Junzhi Liu
    Jiangli Zhao
    Xuchen Liu
    Yan Zhang
    Guowei Liu
    Zhimin Zhao
    Wenjie Li
    Qing Zhang
    Xingang Li
    Bin Huang
    Xinyu Wang
    BMC Cancer, 23
  • [22] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhenyu Zhang
    Jinfeng Zhu
    Yansong Huang
    Weibing Li
    Hongqiu Cheng
    Diagnostic Pathology, 13
  • [23] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhang, Zhenyu
    Zhu, Jinfeng
    Huang, Yansong
    Li, Weibing
    Cheng, Hongqiu
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [24] Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway
    Fei, Du
    Wang, Fang
    Wang, Yaohui
    Chen, Ji
    Chen, Shendong
    Fan, Lianpeng
    Yang, Luhan
    Ren, Qingyi
    Duangmano, Suwit
    Du, Fukuan
    Liu, Hao
    Zhou, Jie
    Sheng, Jing
    Zhao, Yueshui
    Wu, Xu
    Li, Mingxing
    Xiao, Zhangang
    Zhang, Zhuo
    Jiang, Xian
    MOLECULAR CANCER, 2024, 23 (01)
  • [25] Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion
    Shulkla, Sanjeev
    MacLennan, Gregory T.
    Hartman, Douglas J.
    Fu, Pingfu
    Resnick, Martin I.
    Gupta, Sanjay
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) : 1424 - 1432
  • [26] ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
    Ni, Sheng
    Wei, Qian
    Yang, Li
    ONCOTARGETS AND THERAPY, 2020, 13 : 12409 - 12419
  • [27] LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway
    Wu, J. -H.
    Tian, X. -Y.
    An, Q-M.
    Guan, X. -Y.
    Hao, C. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1645 - 1652
  • [28] GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway
    Wang, Yadong
    Fang, Xiaosan
    Xie, Hao
    Wang, Xiaoming
    BIOCHEMICAL GENETICS, 2024,
  • [29] Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
    Wang, Houhong
    Chen, Wenli
    Cui, Yayun
    Gong, Huihui
    Tang, Amao
    AGING-US, 2023, 15 (15): : 7831 - 7843
  • [30] TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway
    Man, Jing
    Zhou, Wanbiao
    Zuo, Shi
    Zhao, Xueke
    Wang, Qiang
    Ma, Huaxing
    Li, Hai-Yang
    BIOCHEMICAL PHARMACOLOGY, 2023, 213
12345